{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,3]],"date-time":"2026-09-03T00:04:26Z","timestamp":1788393866248,"version":"build-2803163510"},"reference-count":37,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2019,2,1]],"date-time":"2019-02-01T00:00:00Z","timestamp":1548979200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"name":"Project of Science and Technology Department of Liaoning Province","award":["2015010203"],"award-info":[{"award-number":["2015010203"]}]},{"name":"Project of Liaoning Distinguished Professor","award":["2014"],"award-info":[{"award-number":["2014"]}]},{"name":"Program for Liaoning Innovative Research Team in University","award":["LT 2012018"],"award-info":[{"award-number":["LT 2012018"]}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Chromatography B"],"published-print":{"date-parts":[[2019,2]]},"DOI":"10.1016\/j.jchromb.2018.12.031","type":"journal-article","created":{"date-parts":[[2019,1,4]],"date-time":"2019-01-04T02:25:55Z","timestamp":1546568755000},"page":"35-42","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":11,"special_numbering":"C","title":["Established UPLC-MS\/MS procedure for multicomponent quantitative analysis in rat plasma: A contrastive pharmacokinetics study of Qiangshen tablet in normal and kidney yang deficiency syndrome models"],"prefix":"10.1016","volume":"1106-1107","author":[{"given":"Jinwei","family":"Gao","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jinbo","family":"Yu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Panpan","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jinmei","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guanghui","family":"Gao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Binglong","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lixin","family":"Sun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jchromb.2018.12.031_bb0005","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1016\/j.jpba.2012.12.022","article-title":"An integrated plasma and urinary metabonomic study using UHPLC-MS: intervention effects of Epimedium koreanum on \u2018Kidney-Yang Deficiency syndrome\u2019 rats","volume":"76","author":"Huang","year":"2013","journal-title":"J. Pharm. Biomed. Anal."},{"key":"10.1016\/j.jchromb.2018.12.031_bb0010","first-page":"54","article-title":"Metabolic signatures of Kidney Yang Deficiency syndrome and protective effects of two herbal extracts in rats using GC\/TOF MS","volume":"11","author":"Zhao","year":"2013","journal-title":"Evid. Based Complement. Alternat. Med."},{"key":"10.1016\/j.jchromb.2018.12.031_bb0015","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/j.jep.2012.08.020","article-title":"Curculigo orchioides (Xian Mao) modifies the activity and protein expression of CYP3A in normal and Kidney-Yang Deficiency model rats","volume":"144","author":"Wang","year":"2012","journal-title":"J. Ethnopharmacol."},{"key":"10.1016\/j.jchromb.2018.12.031_bb0020","doi-asserted-by":"crossref","first-page":"700","DOI":"10.1016\/j.talanta.2010.09.026","article-title":"Metabonomic study on \u2018Kidney-Yang Deficiency syndrome'and intervention effects of Rhizoma drynariae extracts in rats using ultra performance liquid chromatography coupled with mass spectrometry","volume":"83","author":"Lu","year":"2011","journal-title":"Talanta"},{"key":"10.1016\/j.jchromb.2018.12.031_bb0025","article-title":"Phenotypic characterization of nanshi oral liquid alters metabolic signatures during disease prevention","volume":"6","author":"Zhang","year":"2016","journal-title":"Sci. Rep."},{"key":"10.1016\/j.jchromb.2018.12.031_bb0030","unstructured":"Pharmacopoeia Commission of PRC, Pharmacopoeia of the People's Republic of China, China Medical Science Press, Beijing, 2015."},{"key":"10.1016\/j.jchromb.2018.12.031_bb0035","article-title":"An integrated chinmedomics strategy for discovery of effective constituents from traditional herbal medicine","volume":"6","author":"Wang*","year":"2016","journal-title":"Sci. Rep."},{"key":"10.1016\/j.jchromb.2018.12.031_bb0040","doi-asserted-by":"crossref","first-page":"372","DOI":"10.1016\/j.jchromb.2017.07.042","article-title":"Comparatively evaluating the pharmacokinetic of fifteen constituents in normal and blood deficiency rats after oral administration of Xin-Sheng-Hua Granule by UPLC\u2013MS\/MS","volume":"1061-1062","author":"Pang","year":"2017","journal-title":"J. Chromatogr. B"},{"key":"10.1016\/j.jchromb.2018.12.031_bb0045","doi-asserted-by":"crossref","first-page":"985","DOI":"10.1111\/j.1939-1676.2011.00780.x","article-title":"The pharmacokinetics of mirtazapine in cats with chronic kidney disease and in age-matched control cats","volume":"25","author":"Quimby","year":"2011","journal-title":"J. Vet. Intern. Med."},{"key":"10.1016\/j.jchromb.2018.12.031_bb0050","doi-asserted-by":"crossref","first-page":"1435","DOI":"10.1016\/j.fitote.2012.08.007","article-title":"Comparative pharmacokinetics of baicalin in normal and the type 2 diabetic rats after oral administration of the Radix scutellariae extract","volume":"83","author":"Yuan","year":"2012","journal-title":"Fitoterapia"},{"key":"10.1016\/j.jchromb.2018.12.031_bb0055","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1016\/j.jep.2012.10.036","article-title":"Effect of acute pancreatitis on the pharmacokinetics of Chinese herbal ointment Liu-He-Dan in anaesthetized rats","volume":"145","author":"Xian","year":"2013","journal-title":"J. Ethnopharmacol."},{"key":"10.1016\/j.jchromb.2018.12.031_bb0060","doi-asserted-by":"crossref","first-page":"456","DOI":"10.3390\/ijms15010456","article-title":"Pharmacokinetic comparison of berberine in rat plasma after oral administration of berberine hydrochloride in normal and post inflammation irritable bowel syndrome rats","volume":"15","author":"Gong","year":"2014","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.jchromb.2018.12.031_bb0065","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1016\/j.jep.2015.07.037","article-title":"Comparative pharmacokinetics of the main compounds of Shanzhuyu extract after oral administration in normal and chronic kidney disease rats","volume":"173","author":"Zhao","year":"2015","journal-title":"J. Ethnopharmacol."},{"key":"10.1016\/j.jchromb.2018.12.031_bb0070","doi-asserted-by":"crossref","first-page":"466","DOI":"10.1016\/j.fitote.2010.12.004","article-title":"Comparative pharmacokinetics of paeoniflorin in plasma of vascular dementia and normal rats orally administrated with Danggui-Shaoyao-San or pure paeoniflorin","volume":"82","author":"Liu","year":"2011","journal-title":"Fitoterapia"},{"key":"10.1016\/j.jchromb.2018.12.031_bb0075","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1016\/j.jpba.2016.05.045","article-title":"Simultaneous determination of nineteen major active compounds in Qiangshen tablet by UPLC-ESI-MS\/MS","volume":"128","author":"Gao","year":"2016","journal-title":"J. Pharm. Biomed. Anal."},{"key":"10.1016\/j.jchromb.2018.12.031_bb0080","first-page":"69","article-title":"Determination of paeoniflorin in Qiangshen tablets by HPLC","volume":"24","author":"Xu","year":"2005","journal-title":"Her. Med."},{"key":"10.1016\/j.jchromb.2018.12.031_bb0085","doi-asserted-by":"crossref","first-page":"692","DOI":"10.1021\/pr3007792","article-title":"Intrarenal metabolomic investigation of chronic kidney disease and its TGF-\u00e21 mechanism in induced-adenine rats using UPLC Q-TOF\/HS-MS\/MSE","volume":"12","author":"Zhao","year":"2013","journal-title":"J. Proteome Res."},{"key":"10.1016\/j.jchromb.2018.12.031_bb0090","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1007\/s101570050015","article-title":"Reversibility of adenine-induced renal failure in rats","volume":"3","author":"Okada","year":"1999","journal-title":"Clin. Exp. Nephrol."},{"key":"10.1016\/j.jchromb.2018.12.031_bb0095","first-page":"3901","article-title":"Comparative study on syndrome of deficiency of kidney yang rat model induced by adenine and hydrocortisone","volume":"30","author":"Tong","year":"2015","journal-title":"Chin. J. Tradit. Chin. Med. Pharm."},{"key":"10.1016\/j.jchromb.2018.12.031_bb0100","first-page":"598","article-title":"Reference standard for syndrome differentiation of deficiency syndrome of traditional Chinese medicine","volume":"10","author":"Shen","year":"1985","journal-title":"Chin. J. Integrated Tradit. Chin. West Med."},{"key":"10.1016\/j.jchromb.2018.12.031_bb0105","first-page":"82","article-title":"Dosing and switching strategies for paliperidone palmitate: based on population pharm-acokinetic modelling and clinical trial data","volume":"25","author":"Samtani","year":"2011","journal-title":"CNS Drugs"},{"key":"10.1016\/j.jchromb.2018.12.031_bb0110","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1007\/s40262-014-0146-1","article-title":"Consequences of renal failure on non-renal clearance of drugs","volume":"53","author":"Lalande","year":"2014","journal-title":"Clin. Pharmacokinet."},{"key":"10.1016\/j.jchromb.2018.12.031_bb0115","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1038\/clpt.2009.190","article-title":"When to conduct a renal impairment study during drug development: U.S. food and drug administration perspective","volume":"86","author":"Huang","year":"2009","journal-title":"Clin. Pharmacol. Ther."},{"key":"10.1016\/j.jchromb.2018.12.031_bb0120","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1124\/dmd.114.061150","article-title":"Effect of experimental kidney disease on the functional expression of hepatic reductases","volume":"43","author":"Alshogran","year":"2015","journal-title":"Drug Metab. Dispos."},{"key":"10.1016\/j.jchromb.2018.12.031_bb0125","doi-asserted-by":"crossref","first-page":"2538","DOI":"10.3390\/ijms15022538","article-title":"Xenobiotic metabolism: the effect of acute kidney injury on non-renal drug clearance and hepatic drug metabolism","volume":"15","author":"Dixon","year":"2014","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.jchromb.2018.12.031_bb0130","first-page":"4","article-title":"Pharmacokinetics research advances of coumar in compounds in vivo, China","volume":"25","author":"Lei","year":"2016","journal-title":"Pharmaceuticals"},{"key":"10.1016\/j.jchromb.2018.12.031_bb0135","first-page":"924","article-title":"Enzyme kinetics of psoralen and isopsoralen in rat and human liver microsomes","volume":"29","author":"Yang","year":"2015","journal-title":"Chin. J. Pharmacol. Toxicol."},{"key":"10.1016\/j.jchromb.2018.12.031_bb0140","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1016\/j.jpba.2017.04.026","article-title":"Studies on the metabolites difference of psoralen\/isopsoralen in human and six mammalian liver microsomes in vitro by UHPLC\u2013MS\/MS","volume":"141","author":"Yong","year":"2017","journal-title":"J. Pharm. Biomed. Anal."},{"key":"10.1016\/j.jchromb.2018.12.031_bb0145","first-page":"467","article-title":"HPLC-ESI\/MS analysis of stachydrine and its metabolites in rat urine","volume":"41","author":"Chen","year":"2006","journal-title":"Acta Pharm. Sin."},{"key":"10.1016\/j.jchromb.2018.12.031_bb0150","doi-asserted-by":"crossref","first-page":"1327","DOI":"10.1378\/chest.11-1396","article-title":"Introduction to drug pharmacokinetics in the critically ill patient","volume":"14","author":"Smith","year":"2012","journal-title":"Chest"},{"key":"10.1016\/j.jchromb.2018.12.031_bb0155","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1016\/j.jchromb.2017.12.025","article-title":"Comparative metabolism of two major compounds in Fructus corni extracts by gut microflora from normal and chronic nephropathy rats in vitro by UPLC-Q-TOF\/MS","volume":"1073","author":"Tao","year":"2018","journal-title":"J. Chromatogr. B"},{"key":"10.1016\/j.jchromb.2018.12.031_bb0160","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1016\/S1674-6384(17)60088-1","article-title":"UPLC-Q-TOF\/MS-based metabolic profiles of bioactive components in Rehmannia glutinosa and Cornus officinalis herb pair by rat intestinal bacteria","volume":"9","author":"Tao","year":"2017","journal-title":"Chin. Herbal Med."},{"key":"10.1016\/j.jchromb.2018.12.031_bb0165","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1111\/j.2042-7158.1997.tb06748.x","article-title":"In-vivo assessment of extrahepatic metabolism of paeoniflorin in rats: relevance to intestinal floral metabolism","volume":"49","author":"Takeda","year":"1997","journal-title":"J. Pharm. Pharmacol."},{"key":"10.1016\/j.jchromb.2018.12.031_bb0170","doi-asserted-by":"crossref","first-page":"1607","DOI":"10.1093\/ndt\/16.8.1607","article-title":"Effect of chronic renal failure on the expression and function of rat intestinal P-glycoprotein in drug excretion","volume":"16","author":"Veau","year":"2001","journal-title":"Nephrol. Dial. Transplant."},{"key":"10.1016\/j.jchromb.2018.12.031_bb0175","doi-asserted-by":"crossref","first-page":"978","DOI":"10.1124\/jpet.106.112631","article-title":"Down-regulation of intestinal drug transporters in chronic ren failure in rats","volume":"320","author":"Naud","year":"2007","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.jchromb.2018.12.031_bb0180","doi-asserted-by":"crossref","first-page":"587","DOI":"10.1097\/MNH.0b013e328358c8d5","article-title":"CKD impairs barrier function and alters microbial flora of the intestine: a major link to inflammation and uremic toxicity","volume":"21","author":"Vaziri","year":"2012","journal-title":"Curr. Opin. Nephrol. Hypertens."},{"key":"10.1016\/j.jchromb.2018.12.031_bb0185","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1007\/s12272-010-0206-5","article-title":"Pharmacokinetics, tissue distribution and excretion of coumarin components from Psoralea corylifolia L. in rats","volume":"33","author":"Feng","year":"2010","journal-title":"Arch. Pharm. Res."}],"container-title":["Journal of Chromatography B"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1570023218306457?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1570023218306457?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,2,19]],"date-time":"2019-02-19T08:18:41Z","timestamp":1550564321000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1570023218306457"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,2]]},"references-count":37,"alternative-id":["S1570023218306457"],"URL":"https:\/\/doi.org\/10.1016\/j.jchromb.2018.12.031","relation":{},"ISSN":["1570-0232"],"issn-type":[{"value":"1570-0232","type":"print"}],"subject":[],"published":{"date-parts":[[2019,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Established UPLC-MS\/MS procedure for multicomponent quantitative analysis in rat plasma: A contrastive pharmacokinetics study of Qiangshen tablet in normal and kidney yang deficiency syndrome models","name":"articletitle","label":"Article Title"},{"value":"Journal of Chromatography B","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jchromb.2018.12.031","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}